Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.…
Bon Natural Life (NASDAQ: BON) is listed on Nasdaq, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 96 employees.
The shares were at 1.045 USD on 20 November 2026, down 45.3% over 52 weeks. Its 52-week range is 0.9500 USD to 1.990 USD: the price is 47.5% below the high and 10.0% above the low.
Its market capitalisation is 8.53M USD.
Bon Natural Life reports return on equity of -3.5%, an operating margin of -45.5% and revenue up 1.9% year over year.
Its debt exceeds its cash by 7.24M USD, a debt-to-equity ratio of 0.21. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.
No upcoming events tracked.